Showing results (1301-1310 of 1,471) with videos related to

Sort By:
Pageof 148
The Journal of Clinical Investigation|October 22, 2024
Sialylated glycoproteins suppress immune cell killing by binding to Siglec-7 and Siglec-9 in prostate cancerRu M Wen, Jessica C Stark, G Edward W Marti, et al.
PLOS Global Public Health|June 26, 2026
Micro-costing for national-scale azithromycin mass drug administration to improve child survival in NigerBrittany Peterson, William Nguyen, Laminou Maliki Haroun, et al.
Infection and Immunity|January 24, 2023
Butyrate Differentiates Permissiveness to Clostridioides difficile Infection and Influences Growth of Diverse C. difficile IsolatesDaniel A Pensinger, Andrea T Fisher, Horia A Dobrila, et al.
Nature|March 25, 2025
MFSD6 is an entry receptor for enterovirus D68Lauren Varanese, Lily Xu, Christine E Peters, et al.
British Journal of Pharmacology|June 18, 2022
RvD1 disrupts nociceptor neuron and macrophage activation and neuroimmune communication, reducing pain and inflammation in gouty arthritis in miceTiago H Zaninelli, Victor Fattori, Telma Saraiva-Santos, et al.
Acta Neuropathologica|December 8, 2023
A new subtype of diffuse midline glioma, H3 K27 and BRAF/FGFR1 co-altered: a clinico-radiological and histomolecular characterisationLucie Auffret, Yassine Ajlil, Arnault Tauziède-Espariat, et al.
Medicine|April 28, 2021
Neonatal consequences of maternal exposure to the chikungunya virus: Case reportsThamirys Cosmo Grillo Fajardo, Rosa Estela Gazeta, Daniel Thome Catalan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 12, 2019
A Phase I and Pharmacokinetic Study of Oral Dabrafenib in Children and Adolescent Patients with Recurrent or Refractory <i>BRAF</i> V600 Mutation-Positive Solid TumorsMark W Kieran, Birgit Geoerger, Ira J Dunkel, et al.
Nature Microbiology|August 7, 2019
An RNA-centric dissection of host complexes controlling flavivirus infectionYaw Shin Ooi, Karim Majzoub, Ryan A Flynn, et al.
Cancer Medicine|January 28, 2023
Assessment of the efficacy and tolerability of ruxolitinib for the treatment of myelofibrosis patients in a real-life setting: An Italian MYNERVA ProjectGiacomo Coltro, Emanuela Sant'Antonio, Giuseppe A Palumbo, et al.
Pageof 148